RNDr. Petr Chlapek, DiS., Ph.D.
Assistant professor, Section of Genetics and Molecular Biology
office: bldg. C13/316
Kamenice 753/5
625 00 Brno
phone: | +420 549 49 3970 |
---|---|
e‑mail: |
Total number of publications: 46
2018
-
Why Differentiation Therapy Sometimes Fails: Molecular Mechanisms of Resistance to Retinoids
International Journal of Molecular Sciences, year: 2018, volume: 19, edition: 1, DOI
2017
-
Uniformity under in vitro conditions: Changes in the phenotype of cancer cell lines derived from different medulloblastoma subgroups.
PLOS ONE, year: 2017, volume: 12, edition: 2, DOI
2014
-
LOX/COX inhibitors enhance the antineoplastic effects of all-trans retinoic acid in osteosarcoma cell lines.
Tumor Biology, year: 2014, volume: 35, edition: 8, DOI
-
Mikroprostředí nádoru – možnosti výzkumu v podmínkách in vitro
Klinická onkologie, year: 2014, volume: 27, edition: Suppl 1
-
The ATRA-induced differentiation of medulloblastoma cells is enhanced with LOX/COX inhibitors: an analysis of gene expression.
Cancer Cell International, year: 2014, volume: 14, edition: June, DOI
2011
-
CD133 expression and identification of CD133/nestin positive cells in rhabdomyosarcomas and rhabdomyosarcoma cell lines
Analytical Cellular Pathology-Cellular Oncology, year: 2011, volume: 34, edition: 6, DOI
-
Changes in gene expression in neuroblastoma and medulloblastoma cell lines during induced differentation by combined treatment with all-trans retinoic acid LOX/COX inhibitors.
Year: 2011, type: Conference abstract
-
Identification of cells with cancer stem cell phenotype in rhabdomyosarcoma.
Year: 2011, type: Conference abstract
-
Intracellular distribution of N-terminal isoforms of the p73 protein in medulloblastoma cell lines
Year: 2011, type: Conference abstract
-
N-terminal P73 protein isoforms in medulloblastoma cell and their involvement in retinoic acid-induced differentation.
Year: 2011, type: Conference abstract